However, the difference for previous smokers in the No SLD cohort was marginally significant, potentially due to the smaller sample size or the presence of other mitigating factors.
← all excerpts
A comprehensive analysis of the impact of smoking on adverse clinical outcomes of steatotic liver diseases.
1
—
—